Etoford

Product Overview

Etoford is a pharmaceutical product containing Etoricoxib as its active ingredient. As a selective COX-2 inhibitor, it falls under the category of nonsteroidal anti-inflammatory drugs (NSAIDs). This medication is specifically designed to alleviate pain and inflammation in conditions including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis. Through its targeted inhibition of the cyclooxygenase-2 enzyme, Etoford effectively reduces inflammatory responses and pain perception, thereby enhancing patients’ mobility and daily functioning.

Therapeutic Indications

Etoford tablets are indicated for the symptomatic treatment of:
– Osteoarthritis
– Rheumatoid arthritis
– Ankylosing spondylitis
– Acute gouty arthritis

These conditions are characterized by chronic joint inflammation, pain, and stiffness that can significantly impair physical function and quality of life. Etoford provides targeted relief from these symptoms.

Administration Guidelines

For optimal results:
– Take orally with water
– Preferably administer with food to minimize gastrointestinal irritation
– Swallow tablets whole; do not crush, chew, or break
– Maintain consistent dosing schedule
– If a dose is missed, take when remembered unless close to next scheduled dose

Mechanism of Action

Etoford exerts its therapeutic effects through selective inhibition of cyclooxygenase-2 (COX-2), the enzyme responsible for prostaglandin synthesis at sites of inflammation. By suppressing prostaglandin production, it effectively:
– Reduces inflammatory responses
– Alleviates pain
– Decreases swelling
– Improves joint mobility

Dosage Protocol

Standard dosing recommendations:
– Osteoarthritis: 60 mg once daily
– Rheumatoid arthritis: 60 mg once daily
– Ankylosing spondylitis: 90 mg once daily
– Acute gouty arthritis: 120 mg once daily (short-term use)

Note: Dosage adjustments may be necessary based on:
– Patient response
– Comorbid conditions
– Risk factors
– Concomitant medications

Therapeutic Advantages

• Effective pain and inflammation control
• Improved joint function and mobility
• Enhanced quality of life for arthritis patients
• Convenient once-daily dosing regimen
• Selective COX-2 inhibition with potentially reduced gastrointestinal effects

Potential Adverse Effects

Commonly reported side effects may include:
– Headache
– Dizziness
– Gastrointestinal discomfort
– Dyspepsia
– Mild edema
– Transaminase elevation

These effects are typically mild and transient. Persistent or severe reactions warrant medical consultation.

Important Safety Information

Contraindications:
– Hypersensitivity to NSAIDs or COX-2 inhibitors
– Active peptic ulcer disease
– Severe hepatic impairment
– Third trimester pregnancy

Precautions:
– Cardiovascular risk assessment required
– Monitor renal function in at-risk patients
– Caution in elderly patients
– Avoid concomitant NSAID use
– Regular monitoring recommended for long-term therapy

Storage Conditions

Proper storage requirements:
– Maintain at controlled room temperature (15-30°C)
– Protect from moisture and light
– Keep in original packaging
– Store out of reach of children
– Do not use beyond expiration date

Medical Disclaimer

The information provided is intended for educational purposes only and should not replace professional medical advice. While we strive for accuracy, this content may not encompass all potential:
– Drug interactions
– Contraindications
– Adverse effects
– Special precautions

Always consult your healthcare provider for:
– Diagnosis
– Treatment decisions
– Medication management
– Individualized medical advice

This information supports but does not replace the essential doctor-patient relationship.